	Screening for Breast Cancer: Imaging Updates. Radiol Clin North Am Bahl M. PMID: 42020069 [PubMed - indexed for MEDLINE]
	Understanding the Effects of Cancer-Related Factors on the Association Between Physical Activity and Quality of Life in Breast Cancer Survivors. J Phys Act Health Schleicher E, Demark-Wahnefried W, Pavela G, Fontaine K, Ivankova N, Pisu M, Martin MY, Schoenberger-Godwin YM, Oster RA, Kenzik KM, Rogers LQ. PMID: 42019937 [PubMed - as supplied by publisher]
	ISG15 as a novel serum biomarker for breast Cancer: Diagnostic and prognostic significance, clinical laboratory applications, and multi-biomarker integration strategies. Clin Chim Acta Rahman S, Al-Zharani M, Afzal M, Alfakeeh S, Al-Blwi NS, Sindi MM, Al-Osaimi MM, Moafa AE, Alghazali SA, Al-Abbasi FA. PMID: 42019747 [PubMed - as supplied by publisher]
	Clinical readiness of microwave imaging for breast cancer: a state-of-the-art review of current evidence and challenges. Prog Biomed Eng (Bristol) Álvarez Sánchez-Bayuela D, López-Brea Alarza T, Giovanetti González R, Romero Castellano C. PMID: 42019510 [PubMed - as supplied by publisher]
	Phase I study of stereotactic ablative radiotherapy (SABR) in inoperable breast cancer. Breast De la Pinta C, Gamero V, Muriel A, Capuz AB, Moris R, Martin M, Alarza M, Montero A, Muñoz MT, Hernanz R, García Bermejo ML, Sancho S. PMID: 42019253 [PubMed - as supplied by publisher]
	Peptide-mediated immunomodulation of tumor microenvironment in triple-negative breast cancer: A comprehensive review. J Pharmacol Exp Ther Bhayo AM, Marcato P, Ahmed M. PMID: 42019163 [PubMed - as supplied by publisher]
	Multicentric Validation of a Complete Blood Count-Based Model for Breast Cancer Risk Stratification in Women Age 40-49 Years. JCO Clin Cancer Inform Araújo DC, Rocha BA, da Silva Lima S, Silva TB, Leite LR, Noce da Silva D, Tostes Pintão MC, de Paula MF, Dos Santos Silva RC, Pereira OJE, de Morais Malvezzi JV, Helena da Silva F, Machado FF, de Moura Pinho K, de Souza Sabino SMP, de Paula LLRJ, da Silva Neto JM, Gomes KB, Carvalho MDG, Ribeiro VM, Kohara MA, Guerreiro da Silva IDC, de Souza PHA. PMID: 42018959 [PubMed - indexed for MEDLINE]
	Focusing on the Advances and Challenges of HER2-Targeted Therapy: Cutting-Edge Breakthroughs in Neoadjuvant Treatment for HER2-Positive Breast Cancer. Technol Cancer Res Treat Shang A, Xiong Y, Li M, Tang W, Wan K, Deng Z, Mao X, Chen H. PMID: 42018935 [PubMed - indexed for MEDLINE]
	Prospective study of the behavior of totally implantable catheters in female oncology patients with mammary hypertrophy. Einstein (Sao Paulo) Portugal MFC, Ponte BJ, Sorbello CCJ, Souza TF, Pinheiro AI, Louzada ACS, Leiderman DBD, Mendes CA, Wolosker N. PMID: 42018828 [PubMed - indexed for MEDLINE]
	Preoperative breast cancer screening before chest masculinization surgery. Breast Cancer Res Treat Schuster CR, Aslami ZV, Taccheri C, Azizi A, Saab D, Coon D, Camp MS, Liang F. PMID: 42018242 [PubMed - indexed for MEDLINE]
	Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis. Breast Cancer Res Treat Pathmarajah T, Gokun Y, Williams N, Sizemore GM, Lefebvre H, Gatti-Mays ME, Slover B, Daniel S, Jitwatcharakomol T, Eckstein J, Andraos T, Young R, Grecula J, Raval R, Singh R, Zhu S, Blakaj D, Chakravarti A, Palmer J, Stover D, Jhawar SR, Beyer S. PMID: 42018017 [PubMed - indexed for MEDLINE]
	Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study. Cancer Med Tripathy D, Blum JL, Karuturi MS, McCune S, Kurian S, Moezi MM, Anderson DM, Ji Y, Pluard TJ, Migas J, Lakhanpal S, Jepsen E, Wang Y, Montelongo MZ, Zhang Z, Cappelleri JC, Gauthier E, Rocque GB. PMID: 42017805 [PubMed - indexed for MEDLINE]
	Characterization of Novel MRI Findings in Idiopathic Granulomatous Mastitis: Diagnostic Significance and Clinical Perspectives. Breast J I, Öztürk ME, Alper F. PMID: 42017767 [PubMed - indexed for MEDLINE]
	Molecular subtypes of breast carcinoma and their association with clinicopathological parameters. J Pak Med Assoc Khaliq E, Shawana S. PMID: 42017714 [PubMed - indexed for MEDLINE]
	Quality of life of breast cancer patients: A comparative study of survivors and patients undergoing radiotherapy in Morocco. J Educ Health Promot Lemmih H, Bakzaza B, Anouar Tadlaoui FZ, El Omari N, Rachiq S, Mohammed Raoui S. PMID: 42016411 [PubMed]
	Inflammatory and Nutritional Biomarkers Predict Response to Neoadjuvant Dual Anti-HER2 Therapy in HER2-Positive Breast Cancer: A Retrospective Cohort Study. Cancer Manag Res , Uyar GC, Ye. PMID: 42016158 [PubMed]
	Low-Dose Tamoxifen for Noninvasive Breast Disease: A Meta-Analysis. J Coll Physicians Surg Pak Wang N, Gong L, Hu G, Ye C. PMID: 42015440 [PubMed - indexed for MEDLINE]
	Multiscale Embedded Gene Co-Expression Network Combined with Mendelian Randomisation Analysis for the Molecular Pathogenesis of Breast Cancer. J Coll Physicians Surg Pak Wang Y, Xie R, Zhang H, Ge Z. PMID: 42015432 [PubMed - indexed for MEDLINE]
	Title: Ultra-processed food intake and postmenopausal breast cancer risk in the NIH-AARP diet and health study. J Natl Cancer Inst O'Connell CP, Burns KF, Hong HG, Kahle L, Liao LM, Madrigal JM, Rising CJ, Sinha R, Khandpur N, Martínez Steele E, Gierach G, Loftfield E. PMID: 42015373 [PubMed - as supplied by publisher]
	NEO-HYPORT: does neoadjuvant radiotherapy improve breast cancer outcomes? An open label, randomised, parallel group, superiority trial to compare the disease-free survival following neoadjuvant versus adjuvant hypofractionated radiotherapy in breast cancer (NEO-HYPORT). Trials Chatterjee S, Chakraborty S, Ahmed R, Agarwal SK, Arun I, Sharma A, Maulik S, Mahajan S. PMID: 42015277 [PubMed - as supplied by publisher]

Articles 1 - 20 / 216832

Page 1 of 10842



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy